IQVIA Virtual Research and Development Solution

Service · Managed service by IQVIA

A virtual R&D model for small and mid-sized biotech companies to bring assets to market.

A managed service for small and mid-sized biotech companies that provides a virtual R&D infrastructure to progress drug assets through clinical development and commercialization. It allows firms to scale rapidly and leverage global expertise while maintaining full control of their assets.

Category: Clinical Trials

Engagement model
Managed service partnership
Delivery
Virtual asset development organization
Industries served
Small and mid-sized biotech companies, emerging biopharma
Target Segments
Small and mid-sized biotech companies
Delivery Model
Virtual asset development organization
Primary Goal
Progress drug assets through later development phases
  • Managed service for small and mid-sized biotech companies
  • Virtual asset development organization model
  • Supports clinical, regulatory, CMC, and commercial strategy
  • Retain full asset control and decision-making power
  • Scale operations rapidly without increasing internal headcount

Overview

IQVIA Virtual Research and Development Solution is a managed service designed for small and mid-sized biotech companies to progress drug assets through later development phases. It provides a virtual asset development organization that acts as a "pop-up shop," offering bespoke project infrastructure for every stage of the process. The service supports asset strategy planning, clinical development design, regulatory operations, CMC strategy, and commercialization. By partnering with IQVIA, emerging biopharma firms can leverage global infrastructure and expertise while retaining full control of their assets and decision-making. This model allows companies to scale operations rapidly without increasing internal headcount, helping them realize more of an asset's value before a potential sale or out-licensing.

Development Lifecycle Support

  • Asset Strategy Planning: The solution provides comprehensive asset strategy planning to help small and mid-sized biotech companies progress their drug assets.
  • Clinical Development Design: IQVIA supports clinical development program design and operational delivery for assets in later research phases.
  • Regulatory and CMC Strategy: The service manages CMC strategy and regulatory operations, including the management of submissions for drug approval.
  • Commercialization Support: IQVIA assists with market preparation, product launch, and global marketing to maximize the potential value of the asset.

Operational Model

  • Virtual Infrastructure: The model offers a virtual asset development organization that functions as a bespoke project infrastructure.
  • Rapid Scalability: Companies can ramp up development activities at high speed without the need to add internal headcount.
  • Decision Control: The partnership ensures that emerging biopharma firms maintain full control of decision-making throughout the process.
  • Global Reach: Clients gain access to IQVIA's global expertise and organizational muscle tailored to their specific project needs.

What's included

  • Clinical, regulatory, CMC, and commercial strategy and operations

Use cases

  • Small biotech companies use the virtual infrastructure to progress drug assets through Phase IIb and III trials without hiring more staff.
  • Emerging biopharma firms leverage IQVIA's regulatory and CMC strategy to manage global drug approval submissions.
  • Mid-sized biotechs utilize commercialization support to prepare for product launch and maximize asset value before a potential sale.

Specifications

Engagement model
Managed service partnership
Delivery
Virtual asset development organization
Industries served
Small and mid-sized biotech companies, emerging biopharma
Target Segments
Small and mid-sized biotech companies
Service Scope
Clinical, regulatory, CMC, and commercial strategy and operations
Delivery Model
Virtual asset development organization
Primary Goal
Progress drug assets through later development phases

How it works

  1. Establish Virtual Infrastructure: Small or mid-sized biotech companies partner with IQVIA to establish a virtual asset development organization tailored to their specific drug asset.
  2. Execute Development Strategy: IQVIA provides the global expertise and infrastructure to manage clinical development, regulatory submissions, and CMC strategy.
  3. Scale and Commercialize: The client maintains full decision-making authority while IQVIA handles the operational delivery and global marketing preparation.

FAQ

Who is the IQVIA Virtual Research and Development Solution for?

The solution is specifically designed for small and mid-sized biotech companies that need to progress drug assets through later development phases without scaling internal headcount.

How does the virtual R&D model work?

It functions as a "pop-up shop" or virtual asset development organization, providing a bespoke project infrastructure that supports everything from strategy to commercialization.

Do companies retain control of their assets?

Yes, the model is designed so that emerging biopharma firms retain full control of their assets and all decision-making while leveraging IQVIA's infrastructure.

What stages of drug development does this service support?

The service covers asset strategy planning, clinical development design, regulatory operations, CMC strategy, and commercialization support.

Added by AntSpace from public sources (iqvia.com).

Related

More services by IQVIA